ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal
Jan 16 (Reuters) - Institutional Shareholder Services on Friday recommended that shareholders approve plans by Kleenex maker Kimberly-Clark to buy Tylenol maker Kenvue, saying a tie-up could improve financial metrics.
"On balance, support for the transaction is warranted," wrote ISS, whose recommendations often guide how large investors vote on hot button issues like mergers and who serves on boards. Shareholders will vote on January 29.
(Reporting by Svea Herbst-BaylissEditing by Mark Potter)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Asseto Finance Achieves Regulatory Milestone for RWA Tokenization in Hong Kong
Transportation sector severely impacted by sudden surge in fuel prices
Erase the Fiat Illusion: 5 Altcoins Ready to Explode 10–25% This Week
Day One (DAWN) Soars 100% on $2.5-Billion Merger
Trending news
MoreCrypto prices
More
